Cite
HARVARD Citation
Morgan, R. et al. (2021). Objective responses to first-line neoadjuvant carboplatin–paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial. Lancet oncology. 22 (2), pp. 277-288. [Online].